Project Name：Pregabalin 

Registration Classification：3+6

Formulations and specifications ：Capsule: 150mg 

Indications：For the treatment of diabetic peripheral neuropathic pain , postherpetic neuralgia and adjunctive therapy of epilepsy partial seizures

Original Research Company：Pfizer Manufacturing Deutschland GmbH, Betriebsstatte Freiburg (Germany) 

Progress ：Pharmaceutical Research in progress